Cargando…
The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapy
BACKGROUND: Early tumor shrinkage (ETS) has been identified as a promising imaging biomarker for patients undergoing immunotherapy for several cancer entities. This study aimed to validate the potential of ETS as an imaging biomarker for patients undergoing immunotherapy for hepatocellular carcinoma...
Autores principales: | Müller, Lukas, Gairing, Simon Johannes, Kloeckner, Roman, Foerster, Friedrich, Schleicher, Eva Maria, Weinmann, Arndt, Mittler, Jens, Stoehr, Fabian, Halfmann, Moritz Christian, Düber, Christoph, Galle, Peter Robert, Hahn, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509639/ https://www.ncbi.nlm.nih.gov/pubmed/36153569 http://dx.doi.org/10.1186/s40644-022-00487-x |
Ejemplares similares
-
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates
por: Müller, Lukas, et al.
Publicado: (2023) -
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy
por: Müller, Lukas, et al.
Publicado: (2022) -
Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?
por: Müller, Lukas, et al.
Publicado: (2021) -
Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index
por: Müller, Lukas, et al.
Publicado: (2021) -
Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC
por: Müller, Lukas, et al.
Publicado: (2022)